• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经生长激素治疗的普拉德-威利综合征生长图表。

Growth charts for non-growth hormone treated Prader-Willi syndrome.

作者信息

Butler Merlin G, Lee Jaehoon, Manzardo Ann M, Gold June-Anne, Miller Jennifer L, Kimonis Virginia, Driscoll Daniel J

机构信息

Departments of Psychiatry and Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, Kansas;

Institute for Measurement, Methodology, Analysis & Policy, Texas Tech University, Lubbock, Texas;

出版信息

Pediatrics. 2015 Jan;135(1):e126-35. doi: 10.1542/peds.2014-1711. Epub 2014 Dec 8.

DOI:10.1542/peds.2014-1711
PMID:25489013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4279067/
Abstract

OBJECTIVE

The goal of this study was to generate and report standardized growth curves for weight, height, head circumference, and BMI for non-growth hormone-treated white male and female US subjects with Prader-Willi syndrome (PWS) between 3 and 18 years of age and develop standardized growth charts.

METHODS

Anthropometric measures (N = 133) were obtained according to standard methods from 120 non-growth hormone-treated white subjects (63 males and 57 females) with PWS between 3 and 18 years of age. Standardized growth curves were developed for the third, 10th, 25th, 50th, 75th, 90th, and 97th percentiles by using the LMS method for weight, height, head circumference, and BMI for PWS subjects along with the normative third, 50th, and 97th percentiles from national and international growth data. The LMS smoothing procedure summarized the distribution of the anthropometric variables at each age using three parameters: power of the Box-Cox transformation λ (L), median μ (M) and coefficient of variation δ (S).

RESULTS

Weight, height, head circumference, and BMI standardized growth charts representing 7 percentile ranges were developed from 120 non-growth hormone-treated white male and female US subjects with PWS (age range: 3-18 years) and normative third, 50th, and 97th percentiles from national and international data.

CONCLUSIONS

We encourage the use of syndrome-specific growth standards to examine and evaluate subjects with PWS when monitoring growth patterns and determining nutritional and obesity status. These variables can be influenced by culture, individual medical care, diet intervention, and physical activity plans.

摘要

目的

本研究的目的是生成并报告3至18岁未接受生长激素治疗的美国普拉德-威利综合征(PWS)白人男性和女性的体重、身高、头围和BMI的标准化生长曲线,并制定标准化生长图表。

方法

按照标准方法,对120名3至18岁未接受生长激素治疗的PWS白人受试者(63名男性和57名女性)进行人体测量(N = 133)。使用LMS方法,为PWS受试者的体重、身高、头围和BMI制定第3、第10、第25、第50、第75、第90和第97百分位数的标准化生长曲线,并结合来自国家和国际生长数据的标准第3、第50和第97百分位数。LMS平滑程序使用三个参数总结了每个年龄的人体测量变量分布:Box-Cox变换的幂λ(L)、中位数μ(M)和变异系数δ(S)。

结果

根据120名3至18岁未接受生长激素治疗的美国PWS白人男性和女性受试者以及国家和国际数据的标准第3、第50和第97百分位数,制定了代表7个百分位数范围的体重、身高、头围和BMI标准化生长图表。

结论

我们鼓励在监测生长模式和确定营养及肥胖状况时,使用特定综合征的生长标准来检查和评估PWS受试者。这些变量可能会受到文化、个体医疗护理、饮食干预和体育活动计划的影响。

相似文献

1
Growth charts for non-growth hormone treated Prader-Willi syndrome.未经生长激素治疗的普拉德-威利综合征生长图表。
Pediatrics. 2015 Jan;135(1):e126-35. doi: 10.1542/peds.2014-1711. Epub 2014 Dec 8.
2
Growth Charts for Prader-Willi Syndrome During Growth Hormone Treatment.普拉德-威利综合征在生长激素治疗期间的生长图表
Clin Pediatr (Phila). 2016 Sep;55(10):957-74. doi: 10.1177/0009922815617973. Epub 2016 Feb 3.
3
Growth standards of infants with Prader-Willi syndrome.普拉德-威利综合征婴儿的生长标准。
Pediatrics. 2011 Apr;127(4):687-95. doi: 10.1542/peds.2010-2736. Epub 2011 Mar 14.
4
Disease-specific growth charts for Korean infants with Prader-Willi syndrome.针对患有普拉德-威利综合征的韩国婴儿的疾病特异性生长图表。
Am J Med Genet A. 2015 Jan;167A(1):86-94. doi: 10.1002/ajmg.a.36816. Epub 2014 Oct 22.
5
Growth charts for Thai children with Prader-Willi syndrome aged 0-18 years.泰国患有普拉德-威利综合征的儿童生长图表 0-18 岁。
Orphanet J Rare Dis. 2020 May 6;15(1):111. doi: 10.1186/s13023-020-01388-7.
6
Growth patterns of Chinese patients with Prader-Willi syndrome.中国普拉德-威利综合征患者的生长模式。
Congenit Anom (Kyoto). 2015 Nov;55(4):173-7. doi: 10.1111/cga.12111.
7
Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.普拉德-威利综合征患者对生长激素治疗的反应:体格学标准与基因诊断
J Paediatr Child Health. 2013 Dec;49(12):1045-51. doi: 10.1111/jpc.12294. Epub 2013 Jun 19.
8
[Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years].《中国0至18岁儿童青少年身高、体重标准化生长曲线图》
Zhonghua Er Ke Za Zhi. 2009 Jul;47(7):487-92.
9
Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.生长激素随机对照试验:对一大组普拉德-威利综合征患儿人体测量学、身体成分和身体比例的影响
Clin Endocrinol (Oxf). 2008 Sep;69(3):443-51. doi: 10.1111/j.1365-2265.2008.03228.x. Epub 2008 Mar 18.
10
Growth reference for Saudi preschool children: LMS parameters and percentiles.沙特学龄前儿童的生长参考标准:LMS参数与百分位数
Ann Saudi Med. 2016 Jan-Feb;36(1):2-6. doi: 10.5144/0256-4947.2016.2.

引用本文的文献

1
The influence of genotype makeup on the effectiveness of growth hormone therapy in children with Prader-Willi syndrome.基因型构成对普拉德-威利综合征患儿生长激素治疗效果的影响。
BMC Pediatr. 2024 Oct 1;24(1):627. doi: 10.1186/s12887-024-05109-y.
2
Standardized growth charts for children with osteogenesis imperfecta.成骨不全症患儿的标准化生长图表。
Pediatr Res. 2023 Sep;94(3):1075-1082. doi: 10.1038/s41390-023-02550-0. Epub 2023 Mar 15.
3
Premature adrenarche in Prader-Willi syndrome is associated with accelerated pre-pubertal growth and advanced bone age.普拉德-威利综合征中的性早熟与青春期前生长加速和骨龄提前有关。
J Pediatr Endocrinol Metab. 2022 Dec 5;36(2):185-194. doi: 10.1515/jpem-2022-0468. Print 2023 Feb 23.
4
Genetic conditions of short stature: A review of three classic examples.遗传因素导致的身材矮小:三个经典案例回顾。
Front Endocrinol (Lausanne). 2022 Oct 21;13:1011960. doi: 10.3389/fendo.2022.1011960. eCollection 2022.
5
Prader-Willi syndrome: reflections on seminal studies and future therapies.普拉德-威利综合征:对开创性研究和未来疗法的思考。
Open Biol. 2020 Sep;10(9):200195. doi: 10.1098/rsob.200195. Epub 2020 Sep 23.
6
Growth Trajectories in Genetic Subtypes of Prader-Willi Syndrome.遗传型普拉德-威利综合征的生长轨迹。
Genes (Basel). 2020 Jul 2;11(7):736. doi: 10.3390/genes11070736.
7
Mowat-Wilson syndrome: growth charts.Mowat-Wilson 综合征:生长图表。
Orphanet J Rare Dis. 2020 Jun 15;15(1):151. doi: 10.1186/s13023-020-01418-4.
8
Growth charts for Thai children with Prader-Willi syndrome aged 0-18 years.泰国患有普拉德-威利综合征的儿童生长图表 0-18 岁。
Orphanet J Rare Dis. 2020 May 6;15(1):111. doi: 10.1186/s13023-020-01388-7.
9
Early Diagnosis in Prader-Willi Syndrome Reduces Obesity and Associated Co-Morbidities.早诊早治普拉德-威利综合征可减少肥胖及其相关并发症。
Genes (Basel). 2019 Nov 6;10(11):898. doi: 10.3390/genes10110898.
10
New Features for Child Metrics: Further Growth References and Blood Pressure Calculations.儿童生长指标新增功能:更多生长参考值和血压计算。
J Clin Res Pediatr Endocrinol. 2020 Jun 3;12(2):125-129. doi: 10.4274/jcrpe.galenos.2019.2019.0127. Epub 2019 Sep 2.

本文引用的文献

1
Growth hormone receptor (GHR) gene polymorphism and Prader-Willi syndrome.生长激素受体(GHR)基因多态性与普拉德-威利综合征。
Am J Med Genet A. 2013 Jul;161A(7):1647-53. doi: 10.1002/ajmg.a.35980. Epub 2013 May 21.
2
Effects of growth hormone treatment in adults with Prader-Willi syndrome.生长激素治疗对普拉德-威利综合征成年患者的影响。
Growth Horm IGF Res. 2013 Jun;23(3):81-7. doi: 10.1016/j.ghir.2013.01.001. Epub 2013 Feb 19.
3
Development and implementation of electronic growth charts for infants with Prader-Willi syndrome.开发和实施普拉德-威利综合征婴儿的电子生长图表。
Am J Med Genet A. 2012 Nov;158A(11):2743-9. doi: 10.1002/ajmg.a.35581. Epub 2012 Aug 17.
4
Prader-Willi syndrome.普拉德-威利综合征。
Genet Med. 2012 Jan;14(1):10-26. doi: 10.1038/gim.0b013e31822bead0. Epub 2011 Sep 26.
5
Prader-Willi Syndrome: Obesity due to Genomic Imprinting.普拉德-威利综合征:基因组印迹导致的肥胖症。
Curr Genomics. 2011 May;12(3):204-15. doi: 10.2174/138920211795677877.
6
Nutritional phases in Prader-Willi syndrome.普拉德-威利综合征的营养阶段。
Am J Med Genet A. 2011 May;155A(5):1040-9. doi: 10.1002/ajmg.a.33951. Epub 2011 Apr 4.
7
Growth standards of infants with Prader-Willi syndrome.普拉德-威利综合征婴儿的生长标准。
Pediatrics. 2011 Apr;127(4):687-95. doi: 10.1542/peds.2010-2736. Epub 2011 Mar 14.
8
Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome.普拉德-威利综合征成年患者的身体成分、内分泌及代谢特征
Growth Horm IGF Res. 2010 Jun;20(3):179-84. doi: 10.1016/j.ghir.2009.12.004. Epub 2010 Mar 3.
9
Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).生长激素治疗可使普拉德-威利综合征患者的成人身高完全正常化,并改善身体成分:来自辉瑞国际生长数据库(KIGS)的经验。
Horm Res. 2008;70(3):182-7. doi: 10.1159/000145019. Epub 2008 Jul 29.
10
Thyroid function studies in Prader-Willi syndrome.普拉德-威利综合征的甲状腺功能研究。
Am J Med Genet A. 2007 Mar 1;143A(5):488-92. doi: 10.1002/ajmg.a.31683.